secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensei Biotherapeutics, Inc. (SNSE)
CIK:        0001829802
Form:       8-K
Filed at:   2026-06-15T12:16:14+00:00
Accession:  0001193125-26-270330
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 1.02, 5.02, 5.03, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Faeth Therapeutics (fka Sensei) appoints new CEO, CFO; PIKTOR Phase 2 data expected H2 2026
--------------------------------------------------------------------------------

- Name changed to Faeth Therapeutics; ticker to FTH effective June 16, 2026; Austin HQ.
- Anand Parikh appointed Chairman, President & CEO; Brian Stephenson appointed CFO.
- Board adds former FDA Commissioner Stephen M. Hahn and Saira Ramasastry.
- Series B preferred stock converted; $200M gross proceeds from Feb 2026 private placement.
- PIKTOR (oral PI3K/AKT/mTOR inhibitor) Phase 2 topline data in advanced endometrial cancer expected H2 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829802/000119312526270330/0001193125-26-270330-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829802/000119312526270330/d144622d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-270330

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer